Details of the Drug

General Information of Drug (ID: DM4RNOT)

Drug Name
MLR-1023
Synonyms Oral kinase activator (theraTRACE, oral, type 2 diabetes), Melior
Indication
Disease Entry ICD 11 Status REF
Obesity 5B81 Phase 2 [1]
Type-2 diabetes 5A11 Phase 2 [2]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
Chemical Identifiers
Formula
C11H10N2O2
Canonical SMILES
CC1=CC(=CC=C1)OC2=CNC(=O)N=C2
InChI
InChI=1S/C11H10N2O2/c1-8-3-2-4-9(5-8)15-10-6-12-11(14)13-7-10/h2-7H,1H3,(H,12,13,14)
InChIKey
HJQILFPVRNHTIG-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
39065
ChEBI ID
CHEMBL8030
CAS Number
41964-07-2
UNII
MU3JD8E9IS
DrugBank ID
DB16841
TTD ID
D0ZU4U
Drug-Molecule Activity Atlas (DMA)NEW Click to Jump to the Detailed DMA Information of This Drug
Drug Pharmacogenomic Perturbation (DPP)NEW Click to Jump to the Detailed DPP Information of This Drug
Drug ADMET Endpoint Profile (DAE)NEW Click to Jump to the Detailed DAE Information of This Drug
Repurposed Drugs (RPD) Click to Jump to the Detailed RPD Information of This Drug

References

1 ClinicalTrials.gov (NCT02317796) Adult Subjects With Uncontrolled Type 2 Diabetes. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)